MDGL

Madrigal Pharmaceuticals (MDGL)

About Madrigal Pharmaceuticals (MDGL)

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Details

Daily high

$524.45

Daily low

$509.00

Price at open

$513.28

52 Week High

$615.00

52 Week Low

$333.24

Market cap

11.9B

Dividend yield

0.00%

Volume

296,763

Avg. volume

384,078

P/E ratio

-39.90

Madrigal Pharmaceuticals News